A Proposal for reframing schizophrenia research

Journal of Nervous and Mental Disease

Volumn 201, Issue 9, 2013, Pages 744-752

  Molina, Vicente ^a,b   Blanco, José A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

gamma oscillations; replication; research; Schizophrenia

Indexed keywords

AMPHETAMINE; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; PROTEIN P53; RISPERIDONE;

AUTISM; BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; COPY NUMBER VARIATION; DELUSION; DEPRESSION; DIFFUSION TENSOR IMAGING; DISTRESS SYNDROME; DOPAMINE RELEASE; EMOTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC TRANSMISSION; GENETIC VARIABILITY; GRAY MATTER; HUMAN; MEDICAL RESEARCH; MEMORY; META ANALYSIS (TOPIC); NEGATIVE SYNDROME; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; POSITIVE AND NEGATIVE SYNDROME SCALE; PROGNOSIS; REMISSION; RESTING STATE NETWORK; REVIEW; SCHIZOPHRENIA; SENSORY STIMULATION; TREATMENT RESPONSE; VOXEL BASED MORPHOMETRY; WHITE MATTER; WORKING MEMORY;

ANTIPSYCHOTIC AGENTS; BRAIN; DISPLACEMENT (PSYCHOLOGY); DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERPERSONAL RELATIONS; MENTAL PROCESSES; NERVE NET; NEURAL INHIBITION; PSYCHOPHYSIOLOGY; RECEPTORS, N-METHYL-D-ASPARTATE; REPRODUCIBILITY OF RESULTS; RESEARCH; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 84883631014     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3182a21444     Document Type: Review

References (131)

1. Abi-Dargham A, Kegeles LS, Zea-Ponce Y, Mawlawi O, Martinez D, Mitropoulou V, O'Flynn K, Koenigsberg HW, Van Heertum R, Cooper T, Laruelle M, Siever LJ (2004) Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry. 55: 1001-1006. (Pubitemid 38584612)
2. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52: 258-266.
3. Amador XF, Kirkpatrick B, Buchanan RW, Carpenter WT, Marcinko L, Yale SA (1999) Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry. 156: 637-639. (Pubitemid 29162989)
4. Ammari N, Heinrichs RW, Miles AA (2010) An investigation of 3 neurocognitive subtypes in schizophrenia. Schizophr Res. 121: 32-38.
5. Andreasen NC, Carpenter WT Jr (1993) Diagnosis and classification of schizophrenia. Schizophr Bull. 19: 199-214. (Pubitemid 23183145)
6. Berner P (2002) Conceptualization of vulnerability models for schizophrenia: Historical aspects. Am J Med Genet. 114: 938-942. (Pubitemid 35379237)
7. Berrios GE, Luque R, Villagrán JM (2003) Schizophrenia: A conceptual history. Int J Psychol Psychol Ther. 3: 111-140.
8. Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, Yucel M, Velakoulis D, Pantelis C (2011) Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysis. Schizophr Res. 127: 46-57.
9. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S (2004) Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res. 70: 315-329. (Pubitemid 39141109)
10. Buchanan RW (2007) Persistent negative symptoms in schizophrenia: An overview. Schizophr Bull. 33: 1013-1022. (Pubitemid 47216643)
11. Buchanan RW, Carpenter WT Jr (1997) The neuroanatomies of schizophrenia. Schizophr Bull. 23: 367-372. (Pubitemid 27427979)
12. Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K (2003) Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res. 64: 53-62. (Pubitemid 37153349)
13. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper Langston K, Kessler R (1987) Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients. Biol Psychiatry. 22: 479-494. (Pubitemid 17041628)
14. Buzsáki G (2006a) Coupling of systems by oscillations. Rythms of the brain (pp 334-356). New York: Oxford University Press.
15. Buzsáki G (2006b) Tough problems. Rythms of the brain (pp 357-372). New York: Oxford University Press.
16. Cahn W, Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, Durston S, Koning H, Van Der Linden JA, Kahn RS (2002) Brain morphology in antipsychotic-naive schizophrenia: A study of multiple brain structures. Br J Psychiatry Suppl. 43:s66Ys72. (Pubitemid 34983515)
17. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM (1999) Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry. 56: 162-168. (Pubitemid 29081391)
18. Carpenter WT, Koenig JI (2008) The evolution of drug development in schizophrenia: Past issues and future opportunities. Neuropsychopharmacology. 33: 2061-2079. (Pubitemid 351992095)
19. Carpenter WT Jr, Kirkpatrick B (1988) The heterogeneity of the long-term course of schizophrenia. Schizophr Bull. 14: 645-652.
20. Chakos MH, Lieberman JA, Alvir J, Bilder R, Ashtari M (1995) Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clo-zapine. Lancet. 345: 456-457.
21. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M (1994) Increase in caudate nuclei volumes of firstepisode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry. 151: 1430-1436. (Pubitemid 24301686)
22. Crespi BJ, Crofts HJ (2012) Association testing of copy number variants in schizophrenia and autism spectrum disorders. J Neurodev Disord. 4: 15.
23. Diez A, Suazo V, Casado P, Martin-Loeches M, Molina V (2013) Spatial distribution and cognitive correlates of gamma noise power in schizophrenia. Psychol Med. 43: 1175-1185.
24. Doesburg SM, Roggeveen AB, Kitajo K, Ward LM (2008) Large-scale gammaband phase synchronization and selective attention. Cereb Cortex. 18: 386-396. (Pubitemid 351197797)
25. Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A, Caltagirone C, Bossu P, McDonald C, Gill M, Corvin AP, Spalletta G (2010) Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia. Neuropsychopharmacology. 35: 368-373.
26. Egerton A, Fusar-Poli P, Stone JM (2012) Glutamate and psychosis risk. Curr Pharm Des. 18: 466-478.
27. Elkashef AM, Doudet D, Bryant T, Cohen RM, Li SH, Wyatt RJ (2000) 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography. Psychiatry Res. 100: 1-11.
28. Fanous AH, Neale MC, Webb BT, Straub RE, O'Neill FA, Walsh D, Riley BP, Kendler KS (2008) Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families. Biol Psychiatry. 64: 121-127.
29. Fornito A, Zalesky A, Pantelis C, Bullmore ET (2012) Schizophrenia, neuroimaging and connectomics. Neuroimage. 62: 2296-2314.
30. Fusar-Poli P, Meyer-Lindenberg A (2012) Striatal presynaptic dopamine in schizophrenia, part II: Meta-analysis of [18F/11C]-DOPA PET studies. Schizophr Bull. 39: 33-42.
31. Galderisi S, Mucci A, Volpe U, Boutros N (2009) Evidence-based medicine and electrophysiology in schizophrenia. Clin EEG Neurosci. 40: 62-77.
32. Gattaz WF (1992) Phospholipase A2 in schizophrenia. Biol Psychiatry. 31: 214-216.
33. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology (Berl). 156: 117-154. (Pubitemid 32702206)
34. Giakoumaki SG, Roussos P, Rogdaki M, Karli C, Bitsios P, Frangou S (2007) Evidence of disrupted prepulse inhibition in unaffected siblings of bipolar disorder patients. Biol Psychiatry. 62: 1418-1422. (Pubitemid 350180720)
35. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, Filipink RA, McConnell JS, Angle B, Meschino WS, Nezarati MM, Asamoah A, Jackson KE, Gowans GC, Martin JA, Carmany EP, Stockton DW, Schnur RE, Penney LS, Martin DM, Raskin S, Leppig K, Thiese H, Smith R, Aberg E, Niyazov DM, Escobar LF, El-Khechen D, Johnson KD, Lebel RR, Siefkas K, Ball S, Shur N, McGuire M, Brasington CK, Spence JE, Martin LS, Clericuzio C, Ballif BC, Shaffer LG, Eichler EE (2012) Phenotypic heterogeneity of geno-mic disorders and rare copy-number variants. N Engl J Med. 367: 1321-1331.
36. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC (1999) Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry. 156: 1342-1348. (Pubitemid 29416529)
37. Gonzalez-Burgos G, Hashimoto T, Lewis DA (2010) Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep. 12: 335-344.
38. Gonzalez-Burgos G, Lewis DA (2012) NMDA receptor hypofunction, parvalbumin-positive neurons and cortical gamma oscillations in schizophrenia. Schizophr Bull. 38: 950-957.
39. Goriely A, Wilkie AO (2012) Paternal age effect mutations and selfish sperma-togonial selection: Causes and consequences for human disease. Am J Hum Genet. 90: 175-200.
40. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 153: 321-330. (Pubitemid 26074706)
41. Grozeva D, Kirov G, Ivanov D, Jones IR, Jones L, Green EK, St Clair DM, Young AH, Ferrier N, Farmer AE, McGuffin P, Holmans PA, Owen MJ, O'Donovan MC, Craddock N (2010) Rare copy number variants: A point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch Gen Psychiatry. 67: 318-327.
42. Gruber O, Falkai P, Schneider-Axmann T, Schwab SG, Wagner M, Maier W (2008) Neuregulin-1 haplotype HAP(ICE) is associated with lower hippo-campal volumes in schizophrenic patients and in non-affected family members. J Psychiatr Res. 43: 1-6.
43. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study. Arch Gen Psychiatry. 57: 1061-1069.
44. Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, Lawrie SM (2006) A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci. 9: 1477-1478. (Pubitemid 44862654)
45. Hall J, Whalley HC, Moorhead TW, Baig BJ, McIntosh AM, Job DE, Owens DG, Lawrie SM, Johnstone EC (2008) Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia. Biol Psychiatry. 64: 428-433.
46. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderling J, Dube KC, Ganev K, Giel R, an der Heiden W, Holmberg SK, Janca A, Lee PW, Leon CA, Malhotra S, Marsella AJ, Nakane Y, Sartorius N, Shen Y, Skoda C, Thara R, Tsirkin SJ, Varma VK, Walsh D, Wiersma D (2001) Recovery from psychotic illness: A 15- and 25-year international follow-up study. Br J Psychiatry. 178: 506-517. (Pubitemid 32531743)
47. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM (2002) Differential hippo-campal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry. 59: 521-529. (Pubitemid 34602934)
48. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G (1994) One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J Psychiatry. 151: 1409-1416. (Pubitemid 24301683)
49. Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology. 12: 426-445. (Pubitemid 28323862)
50. Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Kirvela O, Ruotsalainen U, Vuorio K, Räkköläinen V, Bergman J, Solin O, Kirvelä O, Salokangas RKR (1995) Presynaptic do-pamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet. 346: 1130-1131.
51. Hill K, Mann L, Laws KR, Stephenson CM, Nimmo-Smith I, McKenna PJ (2004) Hypofrontality in schizophrenia: A meta-analysis of functional imaging studies. Acta Psychiatr Scand. 110: 243-256. (Pubitemid 39278982)
52. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M (2003) Progressive structural brain abnormalities and their relationship to clinical outcome: A longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry. 60: 585-594. (Pubitemid 36682316)
53. Honea R, Crow TJ, Passingham D, Mackay CE (2005) Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies. Am J Psychiatry. 162: 2233-2245. (Pubitemid 41740200)
54. Hong LE, Wonodi I, Stine OC, Mitchell BD, Thaker GK (2008) Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry. 63: 17-23. (Pubitemid 350234892)
55. Hossein Fatemi S, Stary JM, Earle JA, Araghi-Niknam M, Eagan E (2005) GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res. 72: 109-122. (Pubitemid 39550982)
56. Houran J, Thalbourne MA, Hartman E (2003a) Comparison of two alternative measures of the boundary construct. Percept Mot Skills. 96: 311-323. (Pubitemid 39109420)
57. Houran J, Thalbourne MA, Lange R (2003b) Methodological note: Erratum and comment on the use of the Revised Transliminality Scale. Conscious Cogn. 12: 140-144. (Pubitemid 36293350)
58. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: Version IIIVThe final common pathway. Schizophr Bull. 35: 549-562.
59. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 66: 13-20.
60. Huber G (1997) The heterogeneous course of schizophrenia. Schizophr Res. 28: 177-185. (Pubitemid 28055665)
61. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V, Lipska BK, Hyde TM, Song J, Rujescu D, Giegling I, Mayilyan K, Proust MJ, Soghoyan A, Caforio G, Callicott JH, Bertolino A, Meyer-Lindenberg A, Chang J, Ji Y, Egan MF, Goldberg TE, Kleinman JE, Lu B, Weinberger DR (2009) A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med. 15: 509-518.
62. Huxley J, Mayr E, Osmond H, Hoffer A (1964) Schizophrenia as a genetic morphism. Nature. 204: 220-221.
63. Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, Uzunov DP, Smalheiser NR, Davis JM, Pandey GN, Pappas GD, Tueting P, Sharma RP, Costa E (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A. 95: 15718-15723. (Pubitemid 29018766)
64. Jawer M (2006) Psychosomatic plasticity: An "emergent property" of personality research? Explore (NY). 2: 115-121.
65. Jobe TH, Harrow M (2005) Long-term outcome of patients with schizophrenia: A review. Can J Psychiatry. 50: 892-900. (Pubitemid 43161743)
66. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, Law AJ (2010) Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci U S A. 107: 15619-15624.
67. Kendell R, Jablensky A (2003) Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 160: 4-12. (Pubitemid 36042419)
68. Keshavan MS, Nasrallah HA, Tandon R (2011) Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: From the elephant to the mouse. Schizophr Res. 127: 3-13.
69. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT Jr (2001) A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry. 58: 165-171. (Pubitemid 32142754)
70. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW (2008) A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry. 65: 746-760. (Pubitemid 351957701)
71. Koolschijn PC, van Haren NE, Bakker SC, Hoogendoorn ML, Hulshoff Pol HE, Kahn RS (2010) Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus. 20: 1010-1017.
72. Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, Kienast T, Bartenstein P, Grunder G (2007) Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: An [18F]fluorodopa/positron emission tomography study. J Neurosci. 27: 8080-8087. (Pubitemid 47173328)
73. Lakatos P, Chen CM, O'Connell MN, Mills A, Schroeder CE (2007) Neuronal oscillations and multisensory interaction in primary auditory cortex. Neuron. 53: 279-292. (Pubitemid 46074398)
74. Lange R, Thalbourne MA, Houran J, Storm L (2000) The revised transliminal-ity scale: Reliability and validity data from a Rasch top-down purification procedure. Conscious Cogn. 9: 591-617.
75. Laruelle M (1998) Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med. 42: 211-221. (Pubitemid 28529874)
76. Lenox RH, Gould TD, Manji HK (2002) Endophenotypes in bipolar disorder. Am J Med Genet. 114: 391-406. (Pubitemid 34525236)
77. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 6: 312-324. (Pubitemid 40469985)
78. Lichtenstein P, Yip B, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population based study. Lancet. 373: 234-239.
79. Linscott RJ, van Os J (2012) An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: On the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med. 43: 1133-1149.
80. Malhotra D, McCarthy S, Michaelson JJ, Vacic V, Burdick KE, Yoon S, Cichon S, Corvin A, Gary S, Gershon ES, Gill M, Karayiorgou M, Kelsoe JR, Krastoshevsky O, Krause V, Leibenluft E, Levy DL, Makarov V, Bhandari A, Malhotra AK, McMahon FJ, Nothen MM, Potash JB, Rietschel M, Schulze TG, Sebat J (2011) High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron. 72: 951-963.
81. Manoach DS (2003) Prefrontal cortex dysfunction during working memory performance in schizophrenia: Reconciling discrepant findings. Schizophr Res. 60: 285-298. (Pubitemid 36184716)
82. Mata I, Perez-Iglesias R, Roiz-Santianez R, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Berja A, Vazquez-Barquero JL, Crespo-Facorro B (2010) Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. Neuroimage. 53: 1016-1022.
83. Mata I, Perez-Iglesias R, Roiz-Santianez R, Tordesillas-Gutierrez D, Gonzalez-Mandly A, Vazquez-Barquero JL, Crespo-Facorro B (2009) A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biol Psychiatry. 65: 535-540.
84. McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B, Bramon E, Filbey F, Quraishi S, Walshe M, Murray RM (2006) Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry. 163: 478-487. (Pubitemid 44469391)
85. McGowan S, Lawrence AD, Sales T, Quested D, Grasby P (2004) Presynaptic do-paminergic dysfunction in schizophrenia: A positron emission tomographic [18F]fluorodopa study. Arch Gen Psychiatry. 61: 134-142. (Pubitemid 38146547)
86. Meda SA, Gill A, Stevens MC, Lorenzoni RP, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, Thaker G, Pearlson GD (2012) Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry. 71: 881-889.
87. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009) Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuro-psychology. 23: 315-336.
88. Molina V, Hernandez JA, Sanz J, Paniagua JC, Hernandez AI, Martin C, Matias J, Calama J, Bote B (2010) Subcortical and cortical gray matter differences between Kraepelinian and non-Kraepelinian schizophrenia patients identified using voxel-based morphometry. Psychiatry Res. 184: 16-22.
89. Molina V, Martin C, Ballesteros A, de Herrera AG, Hernandez-Tamames JA (2011a) Optimized voxel brain morphometry: Association between brain volumes and the response to atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci. 261: 407-416.
90. Molina V, Papiol S, Sanz J, Rosa A, Arias B, Fatjo-Vilas M, Calama J, Hernandez AI, Becker J, Fananas L (2011b) Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients. Neuroimage. 56: 45-51.
91. Molina V, Sanz J, Sarramea F, Benito C, Palomo T (2005) Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity. J Psychiatr Res. 39: 117-127. (Pubitemid 39602636)
92. Molina Rodriguez V, Montz Andree R, Perez Castejon MJ, Capdevila Garcia E, Carreras Delgado JL, Rubia Vila FJ (1996) SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine. Am J Psychiatry. 153: 1343-1346. (Pubitemid 26334211)
93. Moller HJ, Jager M, Riedel M, Obermeier M, Strauss A, Bottlender R (2010) The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: Comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci. 260: 367-384.
94. Murphy KC (2002) Schizophrenia and velo-cardio-facial syndrome. Lancet. 359: 426-430. (Pubitemid 34158957)
95. Murphy KC, Jones LA, Owen MJ (1999) High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 56: 940-945. (Pubitemid 29480131)
96. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A meta-analytic study. Arch Gen Psychiatry. 55: 433-440. (Pubitemid 28237277)
97. Nicodemus KK, Law AJ, Radulescu E, Luna A, Kolachana B, Vakkalanka R, Rujescu D, Giegling I, Straub RE, McGee K, Gold B, Dean M, Muglia P, Callicott JH, Tan HY, Weinberger DR (2010) Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. Arch Gen Psychiatry. 67: 991-1001.
98. Okochi T, Kishi T, Ikeda M, Kitajima T, Kinoshita Y, Kawashima K, Okumura T, Tsunoka T, Inada T, Yamada M, Uchimura N, Iyo M, Sora I, Ozaki N, Ujike H, Iwata N (2009) Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population. Prog Neuro-psychopharmacol Biol Psychiatry. 33: 903-905.
99. Papiol S, Molina V, Desco M, Rosa A, Reig S, Gispert JD, Sanz J, Palomo T, Fananas L (2005) Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene. Neuroimage. 27: 1002-1006. (Pubitemid 41317267)
100. Parnas J (2000) The self and intentionality in the pre-psychotic stages of schizophrenia: A phenomenological study. In Zahavi D (Ed), Exploring the self. Philosophical and psychopathological perspectives on self-experience (pp 115-148). Amsterdam: Benjamins.
101. Peralta V, Cuesta MJ (1999) Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br J Psychiatry. 174: 243-248. (Pubitemid 29147240)
102. Pomarol-Clotet E, Moro N, Sarro S, Goikolea JM, Vieta E, Amann B, Fernandez-Corcuera P, Sans-Sansa B, Monte GC, Capdevila A, McKenna PJ, Salvador R (2011) Failure of de-activation in the medial frontal cortex in mania: Evidence for default mode network dysfunction in the disorder. World J Biol Psychiatry. 13: 616-626.
103. Pomarol-Clotet E, Salvador R, Sarro S, Gomar J, Vila F, Martinez A, Guerrero A, Ortiz-Gil J, Sans-Sansa B, Capdevila A, Cebamanos JM, McKenna PJ (2008) Failure to deactivate in the prefrontal cortex in schizophrenia: Dysfunction of the default mode network? Psychol Med. 38: 1185-1193. (Pubitemid 351950156)
104. Potter D, Summerfelt A, Gold J, Buchanan RW (2006) Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull. 32: 692-700. (Pubitemid 44412856)
105. Propping P (1983) Genetic disorders presenting as " schizophrenia". Karl Bonhoeffer's early view of the psychoses in the light of medical genetics. Hum Genet. 65: 1-10. (Pubitemid 14232983)
106. Robbins K, Roe CA (2010) An empirical test of the theory of morphic resonance by using recognition for Chinese symbols. Explore (NY). 6: 256-262.
107. Rodriguez VM, Andree RM, Castejon MJ, Zamora ML, Alvaro PC, Delgado JL, Vila FJ (1997) Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study. Psychiatry Res. 76: 51-61. (Pubitemid 28088278)
108. Rosen C, Grossman LS, Harrow M, Bonner-Jackson A, Faull R (2011) Diagnostic and prognostic significance of Schneiderian first-rank symptoms: A 20-year longitudinal study of schizophrenia and bipolar disorder. Compr Psychiatry. 52: 126-131.
109. Saas LA, Parnas J (2007) Explaining schizophrenia: The relevance of phenomenology. In Chung MC, Fulford KVM, Graham G (Eds), Reconceiving schizophrenia (pp 63-92). New York: Oxford University Press.
110. Stahl SM, Buckley PF (2007) Negative symptoms of schizophrenia: A problem that will not go away. Acta Psychiatr Scand. 115: 4-11. (Pubitemid 44973546)
111. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Moller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Muhleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nothen MM, Peltonen L, Collier DA, St Clair D, Stefansson K (2008) Large recurrent microdeletions associated with schizophrenia. Nature. 455: 232-236.
112. Strauss JS, Carpenter WT (1981) Schizophrenia. New York: Plenum.
113. Suazo V, Diez A, Martin C, Ballesteros A, Casado P, Martin-Loeches M, Molina V (2012) Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry.
114. Sullivan PF (2010) The psychiatric GWAS consortium: Big science comes to psychiatry. Neuron. 68: 182-186.
115. Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J (1998) Induced gamma-band activity during the delay of a visual short-term memory task in humans. J Neurosci. 18: 4244-4254. (Pubitemid 28243818)
116. Tan HY, Chen Q, Sust S, Buckholtz JW, Meyers JD, Egan MF, Mattay VS, MeyerLindenberg A, Weinberger DR, Callicott JH (2007) Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc Natl Acad Sci U S A. 104: 12536-12541. (Pubitemid 47206173)
117. Teale P, Collins D, Maharajh K, Rojas DC, Kronberg E, Reite M (2008) Cortical source estimates of gamma band amplitude and phase are different in schizophrenia. Neuroimage. 42: 1481-1489.
118. Thalbourne MA, Houran J, Alias AG, Brugger P (2001) Transliminality, brain function, and synesthesia. J Nerv Ment Dis. 189: 190-192. (Pubitemid 32221003)
119. Thompson M, Weickert CS, Wyatt E, Webster MJ (2009) Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res. 43: 970-977.
120. Uhlhaas PJ, Pipa G, Lima B, Melloni L, Neuenschwander S, Nikolic D, Singer W (2009) Neural synchrony in cortical networks: History, concept and current status. Front Integr Neurosci. 3: 17.
121. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci. 11: 100-113.
122. van der Stelt O, Belger A (2007) Application of electroencephalography to the study of cognitive and brain functions in schizophrenia. Schizophr Bull. 33: 955-970. (Pubitemid 47216646)
123. Varnas K, Lawyer G, Jonsson EG, Kulle B, Nesvag R, Hall H, Terenius L, Agartz I (2008) Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Psychiatr Genet. 18: 177-183.
124. Venkataraman A, Whitford TJ, Westin CF, Golland P, Kubicki M (2012) Whole brain resting state functional connectivity abnormalities in schizophrenia. Schizophr Res. 139: 7-12.
125. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 57: 237-245. (Pubitemid 30140433)
126. Wang F, Jiang T, Sun Z, Teng SL, Luo X, Zhu Z, Zang Y, Zhang H, Yue W, Qu M, Lu T, Hong N, Huang H, Blumberg HP, Zhang D (2009) Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. J Psychiatry Neurosci. 34: 181-186.
127. Weinberger DR (1987) Implications of normal brain development for the patho-genesis of schizophrenia. Arch Gen Psychiatry. 44: 660-669. (Pubitemid 17099795)
128. Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, Shenton ME, Green AI, Nieto-Castanon A, LaViolette P, Wojcik J, Gabrieli JD, Seidman LJ (2009) Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A. 106: 1279-1284.
129. Wray NR, Visscher PM (2010) Narrowing the boundaries of the genetic architecture of schizophrenia. Schizophr Bull. 36: 14-23.
130. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 157: 16-25. (Pubitemid 30027416)
131. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter CS (2010) GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci. 30: 3777-3781.